Inactive Instrument

Insiders Nanomix Corporation

Equities

NNMX

US63008H2013

Advanced Medical Equipment & Technology

Insiders

23-11-24	Nanomix Corporation Announces Chief Executive Officer Changes	CI
22-08-31	Nanomix Names Tadd S. Lazarus to Board of Directors	CI
22-08-31	Nanomix Corporation Appoints Tadd S. Lazarus to its Board of Directors as Independent Director	CI
22-07-26	Nanomix Corporation Appoints Thomas Schlumpberger as Member of the Board of Directors	CI
22-07-26	Nanomix Corporation Announces Executive Changes	CI
22-03-30	Nanomix Corporation Appoints Vidur Sahney as Chief Operating Officer	CI
21-06-10	Boston Therapeutics, Inc. Announces Board Changes	CI
21-06-10	Boston Therapeutics, Inc. Announces Resignation of Conroy Cheng, as Its Chief Executive Officer	CI
20-01-10	Boston Therapeutics, Inc. Appoints Conroy Cheng as the Interim Chief Executive Officer and Interim Chief Financial Officer	CI
19-09-25	Boston Therapeutics, Inc Announces Resignation of S. Colin Neill as Member of Board and Audit Committee	CI
18-12-06	Boston Therapeutics, Inc. Announces Resignation of Loraine V. Upham as Chief Operating Officer	CI
18-03-29	Boston Therapeutics, Inc. Announces Board Changes	CI
18-03-27	Boston Therapeutics Creates New Scientific Advisory Board	CI
18-02-20	Boston Therapeutics, Inc Announces New Coo, Loraine V. Upham	CI
17-06-19	Rom Eliaz Resigns as Director of Boston Therapeutics, Inc	CI
16-12-01	Boston Therapeutics, Inc. Appoints Carl W. Rausch as Director	CI
16-11-15	Alan M. Hoberman Resigns as Director of Boston Therapeutics, Inc	CI
16-10-03	Boston Therapeutics, Inc. Appoints Carl W. Rausch as Chief Executive Officer	CI
16-09-20	Boston Therapeutics, Inc. Announces Resignation of Dale H. Conaway as Director and as Member of Each of the Committees	CI
16-09-14	Henry J. Esber, Resigns as Director and as Member of Each of the Committees of Boston Therapeutics	CI
16-06-10	David Platt Resigns from Boston Therapeutics, Inc. as Chairman and Director	CI
16-03-22	Boston Therapeutics, Inc. Announces Executive Changes	CI
15-09-04	Boston Therapeutics, Inc. Announces Executive Changes	CI
15-08-17	Nanomix Appoints Larry K. Wray, Ph.D. as VP of Development	CI
14-11-17	Nanomix, Inc. Appoints Tom Richards as Senior Advisor	CI